Results 41 to 50 of about 51,552 (283)

Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11) [PDF]

Neurology Letters, 2023
IFN-β : All interferons are approved for the treatment of RRMS, moreover Betaferon and Avonex are also approved for the treatment of clinical isolated syndrome (CIS) and Betaferon for the treatment of active secondary progressive MS (SPMS) as well (EMA ...
Zahra Nikoo
doaj  

Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy

The Application of Clinical Genetics, 2021
Paula Triana-Fonseca,1 Juan Fernando Parada-Márquez,1 Claudia T Silva-Aldana,2 Daniela Zambrano-Arenas,1 Laura Lucia Arias-Gomez,2 Natalia Morales-Fonseca,3 Esteban Medina-Méndez,2 Carlos M Restrepo,4 Daniel Felipe Silgado-Guzmán,2 Dora Janeth Fonseca ...
Triana-Fonseca P, Parada-Márquez JF, Silva-Aldana CT, Zambrano-Arenas D, Arias-Gomez LL, Morales-Fonseca N, Medina-Méndez E, Restrepo CM, Silgado-Guzmán DF, Fonseca-Mendoza DJ   +9 more
doaj  

DMD genotypes and motor function in Duchenne muscular dystrophy

, 2023
Background and ObjectivesClinical trials of genotype-targeted treatments in Duchenne muscular dystrophy (DMD) tra-ditionally compare treated patients with untreated patients with the same DMD genotype class.This avoids confounding of drug efficacy by ...
Wong, B.D., Groot, I.J.M. de, Univ Ziekenhuizen Leuven Grp, Aartsma-Rus, A., Lane, H., PRO-DMD-01, Goemans, N., Mercuri, E., Signorovitch, J., Niks, E.H., Muntoni, F., Assoc Francaise Myopathies, Dieye, I., Servais, L., McDonald, C., Sajeev, G., UK NorthStar Clinical Network, Jenkins, M., Guglieri, M., CCHMC, Tian, C.X., Ward, S.J., Manzur, A.Y., Straub, V., Chesshyre, M., DMD Italian Grp   +25 more
core   +1 more source

Cardiological evaluation of DMD gene female mutation carriers.

, 2023
reservedBACKGROUND: la distrofia muscolare di Duchenne (DMD) è una malattia genetica X-linked dovuta a mutazioni del gene DMD, che codifica per distrofina.
MUTTERLE, ANNA
core  

Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy?

, 2016
In Duchenne Muscular Dystrophy (DMD), large clinical trials can only be possible as part of an international multicentric effort. A crucial question for the field is whether the centers involved in clinical trials and in natural history studies have ...
Mercuri E, Battini R, DMD Italian Group
core   +1 more source

A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance

Hepatology Communications, EarlyView., 2022
Abstract Hepatocellular adenomas (HCAs) are benign liver tumors associated with bleeding or malignant transformation. Data on the indication for surgery are scarce. We analyzed indications and outcome of patients operated for HCAs < 50 mm compared to HCAs ≥ 50 mm. Changes in final postoperative diagnosis were assessed.
Martijn P. D. Haring, Arthur K. E. Elfrink, Christiaan A. J. Oudmaijer, Paul C. M. Andel, Alicia Furumaya, Nenke de Jong, Colin J. J. M. Willems, Thijs Huits, Julie M. L. Sijmons, Eric J. T. Belt, Koop Bosscha, Esther C. J. Consten, Mariëlle M. E. Coolsen, Peter van Duijvendijk, Joris I. Erdmann, Paul Gobardhan, Robbert J. de Haas, Tjarda van Heek, Hwai‐Ding Lam, Wouter K. G. Leclercq, Mike S. L. Liem, Hendrik A. Marsman, Gijs A. Patijn, Türkan Terkivatan, Babs M. Zonderhuis, Izaak Quintus Molenaar, Wouter W. te Riele, Jeroen Hagendoorn, Alexander F. M. Schaapherder, Jan N. M. IJzermans, Carlijn I. Buis, Joost M. Klaase, Koert P. de Jong, Vincent E. de Meijer, the Dutch Benign Liver Tumor Group, R. B. Takkenberg, J. Verheij, O. M. van Delden, J. I. Erdmann, B. V. van Rosmalen, A. Furumaya, G. Kazemier, D. Ramsoekh, J. N. M. IJzermans, R. A. de Man, M. D. Doukas, M. G. Thomeer, A. J. Klompenhouwer, A. F. M. Schaapherder, M. E. Tushuizen, M. J. Coenraad, A. S. L. P. Crobach, M. C. Burgmans, S. Feshtali, M. M. E. Coolsen, M. Kramer, J. C. Beckervordersandforth, I. V. Samarska, C. van der Leij, R. Miclea, J. H. W. de Wilt, P. B. van den Boezem, E. T. T. L. Tjwa, I. Munsterman, S. Vos, S. van Koeverden, V. E. de Meijer, F. J. C. Cuperus, R. J. de Haas, E. W. Duiker, M. P. D. Haring   +70 more
wiley   +1 more source

wardle/dmd: dmd v0.5.2

, 2021
Implementation of the UK NHS dictionary of medicines and devices (dm+d)
Mark Wardle
core   +1 more source

Ectodermal dysplasia: a narrative review of the clinical and biological aspects relevant to oral health

Frontiers in Pediatrics
Ectodermal dysplasias (ED) are disorders that affect ectodermal-derived tissues during embryonic development. These disorders occur when the ectoderm, the outermost layer of embryonic tissue does not develop normally.
Ana Carolina Morandini, Oluwatomisin Adeogun, Megan Black, Emily Holman, Kaitlyn Collins, Wesley James, Laura Lally, Ashley Fordyce, Rachel Dobbs, Eve McDaniel, Hannah Putnam, Michael Milano   +11 more
doaj   +1 more source

Influence of a pulsed laser regime on surface finish induced by thedirect metal deposition process on a Ti64 alloy [PDF]

, 2014
tThe direct metal deposition (DMD) laser technique is a free-form metal deposition process, which allowsgenerating a prototype or small series of near net-shape structures.
GORNY, Cyril, CARRON, Denis, LE MASSON, Philippe, GHARBI, Myriam, PEYRE, Patrice, FABBRO, Rémy, CARIN, Muriel, MORVILLE, Simon   +7 more
core   +1 more source

The relationship between patient's participation in shade selection and their satisfaction with their dental prostheses

Clinical and Experimental Dental Research, 2022
Objectives Multiple studies have measured the degree of patients' satisfaction with their dental prostheses. Some found that the preliminary cause for dissatisfaction was attributed to the shade used in the fabrication their prostheses.
Faisal Alzeghaibi, Abdulaziz Jammah, Faisal Alghanim, Khalid Albawardi, Lubna Alkadi   +4 more
doaj   +1 more source